##How far away is the "wonder drug" Radzivir from the patient

I-CAIJING

CAIJING magazine official Wechat. "CAIJING" magazine, sponsored by the China Securities Market Research Center, was first published in 1998, adhering to the news concept of "independence, exclusiveness and originality" , and is known for authoritative, impartial and professional reporting, it is a must-read publication for policy-makers, researchers and managers in the field of politics and economics.

The following article is from 11 people of Finance and Economics, author Li Siyang

Set up by the Industry Reporting Team of Caijing magazine to study the success and failure of enterprises, explore the rise and fall of industries, and promote sunshine business

By Li Siyang, CAIJING correspondent

Editor | Marc

On February 6, the first serious patients with COVID-19 pneumonia were formally tested for the new drug, Remdesivir, at Wuhan's Jinyintan Hospital.

On the afternoon of February 5, Wang Chen, academician of the Chinese Academy of Engineering and former director of the China Japan Friendship Hospital, two professors led by Cao Bin, Director of the Department of respiratory and Critical Care Medicine at china-japan Friendship Hospital, announced at Wuhan Jinyintan Hospital: Start the Phase III clinical study of Redesivir, a total of 761 patients (308 with mild to moderate illness and 435 with severe illness) were enrolled in the study, which was randomized, double-blind, and placebo-controlled, to evaluate the efficacy and safety of Redoxivir in the treatment of COVID-19 infection.

The drug, which is still being tested, was developed by Gilead, the US company, as a treatment for Zaire ebolavirus. On January 31, the Journal The New England Journal of Medicine (Nejm) reported a significant improvement in a severe new coronary in the United States. Based on the principle of "compassionate use of drugs" , the China Food and Drug Administration (CFDA) quickly approved the application for a clinical trial of Ridgeville, which was led by Professor Cao Bin.

When will ridgway become widely available? Science takes time, and no one can be sure of a cure without a randomized, double blind clinical trial, Cao Bin told reporters Feb. 6. Gilead also told the press that it was not yet possible to predict when the drug would be widely available because the efficacy of the drug against COVID-19 was not yet known. But Gilead said a variety of measures would be taken to increase supply given the urgency of the situation.

On the afternoon of February 4th the first shipment of 2,843 boxes of Remdesivir arrived in Beijing. Import clearances show that each dose (150 mg) of Ridgeville costs about $20.

Read more about the outbreak in pictures

Editor in chief | Duanhuang@caijing. COM.CN
This is an original article from CAIJING magazine, which can not be reproduced or mirrored without authorization. For reprinting, please leave a message at the end of the article to request and obtain authorization.

Editor in chief | Duanhuang@caijing. COM.CN

This is an original article from CAIJING magazine, which can not be reproduced or mirrored without authorization. For reprinting, please leave a message at the end of the article to request and obtain authorization.

Go to "discover"-"take a look" browse "friends watching"

Sent

####Send it to take a look

Sending

A scan of wechat
Pay attention to the account


-------------
title: How far away is the "wonder drug" Radzivir from the patient
source: cai-jing-za-zhi-/-cai-jing-shi-yi-ren
authors: _
editors: _
proofreader: _
photographer: _
translator: _
via: https://github.com/2019ncovmemory/nCovMemory
link: https://mp.weixin.qq.com/s/xF2N7eFdDr_flJ54sUAKng
archive: http://archive.today/Vcs6B
snapshot: https://github.com/2019ncovmemory/nCovMemory/blob/master/archive/jpg/443.jpg
lead: Can Ridgway bring light to the fight against the epidemic?
cover: data:image/jpeg;base64,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
